CN Stock MarketDetailed Quotes

603193 Runben Biotechnology

Watchlist
  • 25.93
  • +0.82+3.27%
Not Open Nov 14 15:00 CST
10.49BMarket Cap34.25P/E (TTM)

Runben Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
25.98%1.04B
28.47%744.03M
10.02%166.68M
20.66%1.03B
20.90%823.53M
31.93%579.15M
151.5M
47.06%856.09M
681.16M
438.98M
Operating revenue
25.98%1.04B
28.47%744.03M
10.02%166.68M
20.66%1.03B
20.90%823.53M
31.93%579.15M
--151.5M
47.06%856.09M
--681.16M
--438.98M
Other operating revenue
----
7.35%402.3K
----
49.30%657.8K
----
121.93%374.76K
----
85.75%440.6K
----
--168.86K
Total operating cost
21.23%741.94M
22.33%537.56M
0.86%130.26M
14.78%772.61M
16.53%611.99M
26.53%439.43M
129.15M
51.14%673.14M
525.18M
347.29M
Operating cost
19.61%432.28M
19.55%307.76M
3.36%73.85M
14.99%450.93M
15.47%361.4M
26.23%257.44M
--71.45M
43.47%392.15M
--312.98M
--203.94M
Operating tax surcharges
48.19%11.43M
63.70%8.53M
59.00%2.49M
7.21%9.52M
14.24%7.72M
49.95%5.21M
--1.57M
30.02%8.88M
--6.75M
--3.47M
Operating expense
35.57%282.9M
38.23%213.79M
14.68%50.25M
15.88%268.74M
18.22%208.67M
28.80%154.66M
--43.82M
72.50%231.91M
--176.51M
--120.07M
Administration expense
5.73%21.45M
1.30%14.06M
2.82%7.19M
30.24%32.95M
9.70%20.29M
6.88%13.88M
--7M
20.74%25.3M
--18.49M
--12.99M
Financial expense
-607.98%-30.74M
-462.85%-21.33M
-3,262.73%-10.41M
-230.23%-15.21M
-17.42%-4.34M
-65.26%-3.79M
---309.6K
-21.80%-4.61M
---3.7M
---2.29M
-Interest expense (Financial expense)
-48.27%105.03K
-57.00%69.12K
-59.71%38.12K
-40.20%256.3K
-34.41%203.02K
-29.58%160.77K
--94.62K
-20.25%428.6K
--309.53K
--228.3K
-Interest Income (Financial expense)
-568.33%-30.92M
-435.50%-21.46M
-2,341.86%-10.46M
-203.16%-15.56M
-13.19%-4.63M
-56.90%-4.01M
---428.52K
-24.30%-5.13M
---4.09M
---2.55M
Research and development
34.83%24.61M
22.69%14.76M
22.26%6.88M
31.68%25.69M
29.13%18.26M
32.17%12.03M
--5.63M
43.46%19.51M
--14.14M
--9.1M
Credit Impairment Loss
-54.48%-606.02K
-747.78%-1.85M
-146.04%-425.58K
-320.14%-148.45K
38.90%-392.31K
31.83%-217.68K
---172.97K
-1,350.82%-35.33K
---642.04K
---319.33K
Asset Impairment Loss
-1,003.94%-2.36M
-930.84%-4.15M
-746.06%-2.51M
-113.42%-2.41M
63.55%-213.94K
32.43%-403.07K
---296.09K
53.10%-1.13M
---586.97K
---596.49K
Adjustment items of total operating cost
----
----
----
----
--0.01
----
----
----
----
----
Other net revenue
-38.40%3M
-195.46%-1.52M
-4,205.82%-1.4M
49.78%4.27M
235.04%4.87M
75.19%1.59M
-32.56K
-30.66%2.85M
1.45M
907.19K
Invest income
106.74%1.03M
345.17%472.72K
731.16%151.35K
-59.05%838.63K
-58.10%499.65K
-86.09%106.19K
--18.21K
4.58%2.05M
--1.19M
--763.65K
Asset deal income
-382.42%-236.92K
-381.83%-236.92K
---210.51K
77.67%84.06K
--83.89K
--84.06K
--0
4,681.75%47.31K
----
----
Other revenue
5.73%5.17M
110.29%4.25M
279.59%1.59M
207.32%5.91M
228.34%4.89M
90.66%2.02M
--418.29K
-57.84%1.92M
--1.49M
--1.06M
Operating profit
37.97%298.57M
45.03%204.94M
56.91%35.02M
42.42%264.62M
37.46%216.4M
52.60%141.31M
22.32M
31.88%185.8M
157.43M
92.6M
Add:Non operating Income
1,634.56%5.08M
9,551.06%5.04M
41,541.59%5.03M
34.20%3.32M
-87.79%292.73K
-97.73%52.19K
--12.07K
146.38%2.47M
--2.4M
--2.3M
Less:Non operating expense
2,106.28%112.13K
5,495.12%9.84K
7,740.97%8.23K
1,687.20%10.73K
1,879.70%5.08K
430.07%175.93
--105.02
-99.77%600.4
--256.73
--33.19
Total profit
40.08%303.54M
48.54%209.97M
79.30%40.04M
42.31%267.93M
35.58%216.69M
48.96%141.36M
22.33M
32.93%188.27M
159.83M
94.9M
Less:Income tax cost
18.62%42.65M
36.79%29.94M
277.89%4.57M
48.43%41.9M
26.83%35.96M
33.87%21.89M
--1.21M
34.52%28.23M
--28.35M
--16.35M
Net profit
44.35%260.88M
50.69%180.03M
67.93%35.47M
41.23%226.03M
37.47%180.73M
52.10%119.47M
21.12M
32.66%160.04M
131.48M
78.55M
Net profit from continuing operation
44.35%260.88M
50.69%180.03M
67.93%35.47M
41.23%226.03M
37.47%180.73M
--119.47M
--21.12M
32.66%160.04M
--131.48M
----
Net profit of parent company owners
44.35%260.88M
50.69%180.03M
67.93%35.47M
41.23%226.03M
37.47%180.73M
52.10%119.47M
--21.12M
32.66%160.04M
--131.48M
--78.55M
Earning per share
Basic earning per share
20.75%0.64
25.71%0.44
50.00%0.09
36.17%0.64
39.47%0.53
52.17%0.35
--0.06
30.56%0.47
--0.38
--0.23
Diluted earning per share
20.75%0.64
25.71%0.44
50.00%0.09
36.17%0.64
39.47%0.53
52.17%0.35
--0.06
30.56%0.47
--0.38
--0.23
Other composite income
Total composite income
44.35%260.88M
50.69%180.03M
67.93%35.47M
41.23%226.03M
37.47%180.73M
52.10%119.47M
21.12M
32.66%160.04M
131.48M
78.55M
Total composite income of parent company owners
44.35%260.88M
50.69%180.03M
67.93%35.47M
41.23%226.03M
37.47%180.73M
52.10%119.47M
--21.12M
32.66%160.04M
--131.48M
--78.55M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Guangdong Sinong Accounting Firm (Special General Partnership)
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 25.98%1.04B28.47%744.03M10.02%166.68M20.66%1.03B20.90%823.53M31.93%579.15M151.5M47.06%856.09M681.16M438.98M
Operating revenue 25.98%1.04B28.47%744.03M10.02%166.68M20.66%1.03B20.90%823.53M31.93%579.15M--151.5M47.06%856.09M--681.16M--438.98M
Other operating revenue ----7.35%402.3K----49.30%657.8K----121.93%374.76K----85.75%440.6K------168.86K
Total operating cost 21.23%741.94M22.33%537.56M0.86%130.26M14.78%772.61M16.53%611.99M26.53%439.43M129.15M51.14%673.14M525.18M347.29M
Operating cost 19.61%432.28M19.55%307.76M3.36%73.85M14.99%450.93M15.47%361.4M26.23%257.44M--71.45M43.47%392.15M--312.98M--203.94M
Operating tax surcharges 48.19%11.43M63.70%8.53M59.00%2.49M7.21%9.52M14.24%7.72M49.95%5.21M--1.57M30.02%8.88M--6.75M--3.47M
Operating expense 35.57%282.9M38.23%213.79M14.68%50.25M15.88%268.74M18.22%208.67M28.80%154.66M--43.82M72.50%231.91M--176.51M--120.07M
Administration expense 5.73%21.45M1.30%14.06M2.82%7.19M30.24%32.95M9.70%20.29M6.88%13.88M--7M20.74%25.3M--18.49M--12.99M
Financial expense -607.98%-30.74M-462.85%-21.33M-3,262.73%-10.41M-230.23%-15.21M-17.42%-4.34M-65.26%-3.79M---309.6K-21.80%-4.61M---3.7M---2.29M
-Interest expense (Financial expense) -48.27%105.03K-57.00%69.12K-59.71%38.12K-40.20%256.3K-34.41%203.02K-29.58%160.77K--94.62K-20.25%428.6K--309.53K--228.3K
-Interest Income (Financial expense) -568.33%-30.92M-435.50%-21.46M-2,341.86%-10.46M-203.16%-15.56M-13.19%-4.63M-56.90%-4.01M---428.52K-24.30%-5.13M---4.09M---2.55M
Research and development 34.83%24.61M22.69%14.76M22.26%6.88M31.68%25.69M29.13%18.26M32.17%12.03M--5.63M43.46%19.51M--14.14M--9.1M
Credit Impairment Loss -54.48%-606.02K-747.78%-1.85M-146.04%-425.58K-320.14%-148.45K38.90%-392.31K31.83%-217.68K---172.97K-1,350.82%-35.33K---642.04K---319.33K
Asset Impairment Loss -1,003.94%-2.36M-930.84%-4.15M-746.06%-2.51M-113.42%-2.41M63.55%-213.94K32.43%-403.07K---296.09K53.10%-1.13M---586.97K---596.49K
Adjustment items of total operating cost ------------------0.01--------------------
Other net revenue -38.40%3M-195.46%-1.52M-4,205.82%-1.4M49.78%4.27M235.04%4.87M75.19%1.59M-32.56K-30.66%2.85M1.45M907.19K
Invest income 106.74%1.03M345.17%472.72K731.16%151.35K-59.05%838.63K-58.10%499.65K-86.09%106.19K--18.21K4.58%2.05M--1.19M--763.65K
Asset deal income -382.42%-236.92K-381.83%-236.92K---210.51K77.67%84.06K--83.89K--84.06K--04,681.75%47.31K--------
Other revenue 5.73%5.17M110.29%4.25M279.59%1.59M207.32%5.91M228.34%4.89M90.66%2.02M--418.29K-57.84%1.92M--1.49M--1.06M
Operating profit 37.97%298.57M45.03%204.94M56.91%35.02M42.42%264.62M37.46%216.4M52.60%141.31M22.32M31.88%185.8M157.43M92.6M
Add:Non operating Income 1,634.56%5.08M9,551.06%5.04M41,541.59%5.03M34.20%3.32M-87.79%292.73K-97.73%52.19K--12.07K146.38%2.47M--2.4M--2.3M
Less:Non operating expense 2,106.28%112.13K5,495.12%9.84K7,740.97%8.23K1,687.20%10.73K1,879.70%5.08K430.07%175.93--105.02-99.77%600.4--256.73--33.19
Total profit 40.08%303.54M48.54%209.97M79.30%40.04M42.31%267.93M35.58%216.69M48.96%141.36M22.33M32.93%188.27M159.83M94.9M
Less:Income tax cost 18.62%42.65M36.79%29.94M277.89%4.57M48.43%41.9M26.83%35.96M33.87%21.89M--1.21M34.52%28.23M--28.35M--16.35M
Net profit 44.35%260.88M50.69%180.03M67.93%35.47M41.23%226.03M37.47%180.73M52.10%119.47M21.12M32.66%160.04M131.48M78.55M
Net profit from continuing operation 44.35%260.88M50.69%180.03M67.93%35.47M41.23%226.03M37.47%180.73M--119.47M--21.12M32.66%160.04M--131.48M----
Net profit of parent company owners 44.35%260.88M50.69%180.03M67.93%35.47M41.23%226.03M37.47%180.73M52.10%119.47M--21.12M32.66%160.04M--131.48M--78.55M
Earning per share
Basic earning per share 20.75%0.6425.71%0.4450.00%0.0936.17%0.6439.47%0.5352.17%0.35--0.0630.56%0.47--0.38--0.23
Diluted earning per share 20.75%0.6425.71%0.4450.00%0.0936.17%0.6439.47%0.5352.17%0.35--0.0630.56%0.47--0.38--0.23
Other composite income
Total composite income 44.35%260.88M50.69%180.03M67.93%35.47M41.23%226.03M37.47%180.73M52.10%119.47M21.12M32.66%160.04M131.48M78.55M
Total composite income of parent company owners 44.35%260.88M50.69%180.03M67.93%35.47M41.23%226.03M37.47%180.73M52.10%119.47M--21.12M32.66%160.04M--131.48M--78.55M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Guangdong Sinong Accounting Firm (Special General Partnership)------Rong Cheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data